RAN and fragile X-associated tremor/ataxia syndrome: Moreover, genetic or chemical targeting of serine/arginine protein kinases (SRPK1) that regulate SRSF1 function and cellular distribution selectively suppress RAN translation and toxicity in fly and rodent neuronal models of FXTAS through both direct effects on translation and through nuclear CGG repeat RNA retention.